These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10649967)

  • 1. Synthesis and reactivity of a potential carcinogenic metabolite of tamoxifen: 3,4-dihydroxytamoxifen-o-quinone.
    Zhang F; Fan PW; Liu X; Shen L; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2000 Jan; 13(1):53-62. PubMed ID: 10649967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.
    Fan PW; Zhang F; Bolton JL
    Chem Res Toxicol; 2000 Jan; 13(1):45-52. PubMed ID: 10649966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and reactivity of potential toxic metabolites of tamoxifen analogues: droloxifene and toremifene o-quinones.
    Yao D; Zhang F; Yu L; Yang Y; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2001 Dec; 14(12):1643-53. PubMed ID: 11743747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactivation of tamoxifen to metabolite E quinone methide: reaction with glutathione and DNA.
    Fan PW; Bolton JL
    Drug Metab Dispos; 2001 Jun; 29(6):891-6. PubMed ID: 11353759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The major metabolite of equilin, 4-hydroxyequilin, autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone.
    Zhang F; Chen Y; Pisha E; Shen L; Xiong Y; van Breemen RB; Bolton JL
    Chem Res Toxicol; 1999 Feb; 12(2):204-13. PubMed ID: 10027800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivation of the selective estrogen receptor modulator desmethylated arzoxifene to quinoids: 4'-fluoro substitution prevents quinoid formation.
    Liu H; Liu J; van Breemen RB; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2005 Feb; 18(2):162-73. PubMed ID: 15720120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivation of the selective estrogen receptor modulator acolbifene to quinone methides.
    Liu J; Liu H; van Breemen RB; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2005 Feb; 18(2):174-82. PubMed ID: 15720121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes.
    Iverson SL; Shen L; Anlar N; Bolton JL
    Chem Res Toxicol; 1996 Mar; 9(2):492-9. PubMed ID: 8839054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the p-alkyl substituent on the isomerization of o-quinones to p-quinone methides: potential bioactivation mechanism for catechols.
    Iverson SL; Hu LQ; Vukomanovic V; Bolton JL
    Chem Res Toxicol; 1995 Jun; 8(4):537-44. PubMed ID: 7548733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective estrogen receptor modulator (SERM) lasofoxifene forms reactive quinones similar to estradiol.
    Michalsen BT; Gherezghiher TB; Choi J; Chandrasena RE; Qin Z; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2012 Jul; 25(7):1472-83. PubMed ID: 22642258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that 4-allyl-o-quinones spontaneously rearrange to their more electrophilic quinone methides: potential bioactivation mechanism for the hepatocarcinogen safrole.
    Bolton JL; Acay NM; Vukomanovic V
    Chem Res Toxicol; 1994; 7(3):443-50. PubMed ID: 8075378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.
    Gherezghiher TB; Michalsen B; Chandrasena RE; Qin Z; Sohn J; Thatcher GR; Bolton JL
    Chem Biol Interact; 2012 Mar; 196(1-2):1-10. PubMed ID: 22290292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
    Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and reactivity of the catechol metabolites from the equine estrogen, 8,9-dehydroestrone.
    Zhang F; Yao D; Hua Y; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2001 Jun; 14(6):754-63. PubMed ID: 11409947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactivation of phencyclidine in rat and human liver microsomes and recombinant P450 2B enzymes: evidence for the formation of a novel quinone methide intermediate.
    Driscoll JP; Kornecki K; Wolkowski JP; Chupak L; Kalgutkar AS; O'Donnell JP
    Chem Res Toxicol; 2007 Oct; 20(10):1488-97. PubMed ID: 17892269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of raloxifene to quinoids: potential toxic pathways via a diquinone methide and o-quinones.
    Yu L; Liu H; Li W; Zhang F; Luckie C; van Breemen RB; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2004 Jul; 17(7):879-88. PubMed ID: 15257612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reactivity of o-quinones which do not isomerize to quinone methides correlates with alkylcatechol-induced toxicity in human melanoma cells.
    Bolton JL; Pisha E; Shen L; Krol ES; Iverson SL; Huang Z; van Breemen RB; Pezzuto JM
    Chem Biol Interact; 1997 Sep; 106(2):133-48. PubMed ID: 9366899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the catechol 3,4-Dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins.
    Dehal SS; Kupfer D
    Cancer Res; 1996 Mar; 56(6):1283-90. PubMed ID: 8640815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxo substituents markedly alter the phase II metabolism of alpha-hydroxybutenylbenzenes: models probing the bioactivation mechanisms of tamoxifen.
    Ramakrishna KV; Fan PW; Boyer CS; Dalvie D; Bolton JL
    Chem Res Toxicol; 1997 Aug; 10(8):887-94. PubMed ID: 9282838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.